SEARCH

SEARCH BY CITATION

References

  • 1
    Feldman EC. Comparison of ACTH response and dexamethasone suppression as screening tests in canine hyperadrenocorticism. J Am Vet Med Assoc 1983;182:506510.
  • 2
    Feldman EC, Nelson RW, Feldman MS. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs. J Am Vet Med Assoc 1996;209:772775.
  • 3
    Herrtage ME. Canine hyperadrenocorticism. In: TorranceAG, MooneyCT, eds. Manual of Small Animal Endocrinology, 2nd ed. Gloucester , UK : British Small Animal Veterinary Association; 1998: 5573.
  • 4
    Van Liew CH, Greco DS, Salman MD. Comparison of results of adrenocorticotrophic hormone stimulation and low-dose dexamethasone suppression tests with necropsy findings in dogs: 81 cases (1985–1995). J Am Vet Med Assoc 1997;211:322325.
  • 5
    Lamberts SWJ, Zuiderwijk J., Uitterlinden P., et al. Characterisation of adrenal autonomy in Cushing's syndrome: A comparison between in vivo and in vitro responsiveness of the adrenal gland. J Clin Endocrinol Metab 1989;70:192199.
  • 6
    Cerundolo R., Lloyd DH, McNeil PE, Evans H. An analysis of factors underlying hypotrichosis and alopecia in Irish Water Spaniels in the United Kingdom. Vet Dermatol 2000;11:107122.
  • 7
    Schmeitzel LP, Lothrop CD, Rosenkrantz WS. Congenital adrenal hyperplasia-like syndrome. In: BonaguraJD, KirkRW, eds. Kirk's Current Veterinary Therapy XII. Philadelphia , PA : WB Saunders; 1995: 600604.
  • 8
    Curtis CF, Evans H., Lloyd DH. Investigation of the reproductive and growth hormone status of dogs affected by idiopathic recurrent flank alopecia. J Small Anim Pract 1996;37:417422.
  • 9
    Schmeitzel LP, Lothrop CD. Hormonal abnormalities in Pomeranians with normal coat and in Pomeranians with growth hormone-responsive dermatosis. J Am Vet Med Assoc 1990;197:13331341.
  • 10
    Gould SM, Baines EA, Mannion PA, et al. Use of endogenous ACTH concentration and adrenal ultrasonography to distinguish the cause of canine hyperadrenocorticism. J Small Anim Pract 2001;42:113121.
  • 11
    Reine NJ, Hohenhaus AE, Peterson ME, Patnaik AK. Deoxycortisone secreting adrenocortical carcinoma in a dog. J Vet Intern Med 1999;13:386390.
  • 12
    Norman EJ, Thompson H., Mooney CT. Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia. Vet Rec 1999;144:551554.
  • 13
    Frank LA, Scmeitzel LP, Oliver JW Steroidogenic response of adrenal tissues after administration of ACTH to dogs with hypercortisolaemia. J Am Vet Med Assoc 2001;218:214216.
  • 14
    Boord M., Griffin C. Progesterone secreting adrenal mass in a cat with clinical signs of hyperadrenocorticism. J Am Vet Med Assoc 1999;214:666669.
  • 15
    Selman PJ, Mol JA, Rutteman GR, Rijnbeck A. Progestin treatment in the dog. II. Effects on the hypothalamic-pituitary-adrenocortical axis. Eur J Endocrinol 1994;131:422430.
  • 16
    Turton DB, O'Brian JT, Shakir KMM. Incidental adrenal nodules: Association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone. J Endocrinol Invest 1992;15:789796.
  • 17
    Bondanella M., Campo M., Trasforini G., et al. Evaluation of hormonal function in a series on incidentally discovered adrenal masses. Metabolism 1997;46:107113.
  • 18
    Rossi R., Tauchmanova L., Luciano A., et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: Clinical and biochemical features. J Clin Endocrinol Metab 2000;85:14401448.